Novavax, Inc. (NVAX) : Earnings Preview

Novavax, Inc. (NVAX) is slated to report 2Q 2015 earnings after the close on Monday, August 10th. The clinical-stage vaccine company is expected to report revenue of $9.9 million. Similarly, the EPS is projected to come at loss of ($0.09). A year ago, Novavax lost ($0.08) a share. The Street’s estimates for the quarter represents […] View the full post at: Novavax, Inc. (NVAX) : Earnings Preview Related posts: Pre-Market Earnings (March 12) Pre-Market Earnings for August 8, 2012: CPK, BCE, RL, PPL, TEG, DISH, M, AVT, BIP, IFF, NRG, CSC Intel Posts Q1 Lower Earnings But Says ‘PC Sales Bottomed Out’